Insider · CIK 0002057696
David Ryan Purdue
Files at ABBV (AbbVie Inc.). First filing Mar 6, 2026, latest Mar 6, 2026.
David Ryan Purdue files SEC Form 4 as officer at ABBV (AbbVie Inc.). Since Mar 6, 2026, David Ryan Purdue has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.2M, the latest filed on Mar 6, 2026.
A track record needs three past buys with six months of prices behind them; David Ryan Purdue has 0, so none is measured yet.
The newest scored trade: sold $1.2M of ABBV on Mar 4, 2026, filed Mar 6, 2026, scored 68 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ABBV: AbbVie Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | AbbVie Inc. | $1.2M 5,230 shares | -66% | +42% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 6, 2026 | ABBV ABBVIE INC. | 5,230 0.00% of outstanding | $1.2M | Mar 4, 2026 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | ABBV AbbVie Inc. | FTax withholding Common Stock, $0.01 par value | -2,108 | $232.08 | $489k | 8,468 | Mar 11, 2026 |
| Mar 4, 2026 | ABBV AbbVie Inc. | SOpen-market sale Common Stock, $0.01 par value | -5,230 | $233.56 | $1.2M | 2,654 | Mar 6, 2026 |
| Feb 27, 2026 | ABBV AbbVie Inc. | FTax withholding Common Stock, $0.01 par value | -2,692 | $232.08 | $625k | 7,884 | Mar 3, 2026 |
| Feb 18, 2026 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +2,505 | $0.00 | $0 | 7,010 | Feb 20, 2026 |
| Feb 18, 2026 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +890 | $0.00 | $0 | 7,900 | Feb 20, 2026 |
| Feb 18, 2026 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,292 | $0.00 | $0 | 9,192 | Feb 20, 2026 |
| Feb 18, 2026 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,384 | $0.00 | $0 | 10,576 | Feb 20, 2026 |
| Feb 18, 2026 | ABBV AbbVie Inc. | AGrant or award Option (Right to buy)derivative | +4,875 | $0.00 | $0 | 4,875 | Feb 20, 2026 |
Questions about David Ryan Purdue
Answered from the filings on this page, as of the latest one.
Is David Ryan Purdue buying or selling?
In the last 12 months David Ryan Purdue reported 0 open-market buys worth $0 and 1 open-market sell worth $1.2M on SEC Form 4; the latest was sold $1.2M of ABBV on Mar 4, 2026. Grants, option exercises and tax withholding are not counted.
How did David Ryan Purdue's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Ryan Purdue has 0.
Where does David Ryan Purdue file Form 4?
David Ryan Purdue has filed Form 4 at ABBV (AbbVie Inc.) as SVP, Controller. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.